← All trials
NCT04347980
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2020
- Primary completion
- Jun 30, 2020
- Completion date
- Aug 31, 2020
- First posted
- Apr 15, 2020
- Last posted
- Apr 17, 2020
- Enrollment
- 122
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centre Chirurgical Marie LannelongueLead sponsor
- Centre Chirurgical Marie LannelongueOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.